Total Payments
$5,735
2024 Payments
$282.21
Companies
26
Transactions
269
Medicare Patients
11,203
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$5,635 (98.3%)
Education$100.05 (1.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,635 | 250 | 98.3% |
| Education | $100.05 | 19 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,316 | 46 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $548.91 | 28 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $388.10 | 19 | $0 (2020) |
| PFIZER INC. | $386.29 | 40 | $0 (2019) |
| Boston Scientific Corporation | $376.72 | 8 | $0 (2024) |
| Impulse Dynamics (USA) Inc. | $371.10 | 2 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $343.07 | 22 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $307.18 | 29 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $243.75 | 15 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $242.23 | 13 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $282.21 | 2 | Boston Scientific Corporation ($282.21) |
| 2023 | $449.48 | 2 | Ablacon, Inc. ($241.23) |
| 2022 | $162.85 | 1 | Impulse Dynamics (USA) Inc. ($162.85) |
| 2020 | $71.35 | 4 | SANOFI-AVENTIS U.S. LLC ($19.44) |
| 2019 | $1,106 | 44 | Amgen Inc. ($394.95) |
| 2018 | $1,744 | 100 | Amgen Inc. ($457.12) |
| 2017 | $1,920 | 116 | Amgen Inc. ($444.56) |
All Payment Transactions
269 individual payment records from CMS Open Payments — Page 2 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/13/2019 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 07/30/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $31.54 | General |
| Category: Cardiology | ||||||
| 07/26/2019 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/18/2019 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/09/2019 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $31.83 | General |
| Category: Cardiology | ||||||
| 06/19/2019 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Anemia | ||||||
| 06/17/2019 | BIOTRONIK INC. | — | Food and Beverage | In-kind items and services | $26.86 | General |
| 06/13/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $31.73 | General |
| Category: Cardiology | ||||||
| 05/16/2019 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $25.91 | General |
| Category: Cardiology | ||||||
| 05/14/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/02/2019 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/22/2019 | ARBOR PHARMACEUTICALS, INC. | Edarbi (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/12/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA, INVOKAMET | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/11/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.57 | General |
| Category: Cardiovascular | ||||||
| 04/09/2019 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/13/2019 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $32.22 | General |
| Category: Cardiology | ||||||
| 03/01/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA, INVOKAMET | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/25/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $31.31 | General |
| Category: Cardiology | ||||||
| 02/20/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/14/2019 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $33.71 | General |
| Category: Cardiology | ||||||
| 02/13/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA, INVOKAMET | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/12/2019 | Canon Medical Systems USA, Inc. | — | Food and Beverage | Cash or cash equivalent | $67.51 | General |
| Category: Multiple | ||||||
| 02/06/2019 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: STRUCTURAL HEART | ||||||
| 02/04/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/01/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 37 | 2,892 | 3,874 | $1.6M | $338,763 |
| 2022 | 38 | 2,975 | 3,992 | $1.6M | $371,167 |
| 2021 | 34 | 2,764 | 3,604 | $1.4M | $353,474 |
| 2020 | 40 | 2,572 | 3,913 | $1.3M | $319,480 |
Total Patients
11,203
Total Services
15,383
Medicare Billing
$1.4M
Procedure Codes
165
All Medicare Procedures & Services
165 procedure records from CMS Medicare Utilization — Page 7 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93042 | Interpretation and report of electrical activity of heart using 1-3 leads | Facility | 2020 | 68 | 238 | $7,140 | $1,514 | 21.2% |
| 93793 | Anti-clotting management for patient taking warfarin | Office | 2020 | 11 | 152 | $6,536 | $1,511 | 23.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 12 | 22 | $4,752 | $1,454 | 30.6% |
| 0296T | External ekg recording for more than 48 hours up to 21 days | Office | 2020 | 37 | 42 | $4,074 | $1,119 | 27.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 13 | 15 | $1,380 | $1,050 | 76.1% |
| 0298T | Review and interpretation of external ekg recording for more than 48 hours up to 21 days | Office | 2020 | 37 | 42 | $3,528 | $1,005 | 28.5% |
| 76376 | 3d radiographic procedure | Office | 2020 | 36 | 40 | $13,000 | $924.77 | 7.1% |
| 93295 | Remote evaluations of defibrillator up to 90 days with analysis, review and report | Office | 2020 | 12 | 30 | $8,580 | $810.30 | 9.4% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 17 | 19 | $2,603 | $804.96 | 30.9% |
| 93325 | Doppler ultrasound study of color-directed heart blood flow, rate, and valve function | Office | 2020 | 21 | 30 | $2,610 | $784.27 | 30.0% |
| 93321 | Follow-up or limited heart doppler ultrasound study of heart blood flow, valves, and chambers | Office | 2020 | 18 | 27 | $4,023 | $734.68 | 18.3% |
| 93297 | Remote evaluations of implantable heart and blood vessel monitor system with qualified health care professional analysis, review, and report, up to 30 days | Office | 2020 | 13 | 36 | $2,880 | $688.36 | 23.9% |
| 93325 | Doppler ultrasound study of color-directed heart blood flow, rate, and valve function | Facility | 2020 | 197 | 211 | $2,321 | $621.55 | 26.8% |
| 75571 | Ct scan of heart with evaluation of blood vessel calcium | Facility | 2020 | 24 | 24 | $3,360 | $615.77 | 18.3% |
| 93308 | Follow-up or limited ultrasound examination of heart | Facility | 2020 | 17 | 19 | $2,109 | $453.02 | 21.5% |
About Dr. Nellis Smith, M.D
Dr. Nellis Smith, M.D is a Clinical Cardiac Electrophysiology healthcare provider based in E Palo Alto, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386678951.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nellis Smith, M.D has received a total of $5,735 in payments from pharmaceutical and medical device companies, with $282.21 received in 2024. These payments were reported across 269 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($5,635).
As a Medicare-enrolled provider, Smith has provided services to 11,203 Medicare beneficiaries, totaling 15,383 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 165 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinical Cardiac Electrophysiology
- Other Specialties Nuclear Cardiology, Cardiovascular Disease
- Location E Palo Alto, CA
- Active Since 07/10/2006
- Last Updated 05/28/2020
- Taxonomy Code 207RC0001X
- Entity Type Individual
- NPI Number 1386678951
Products in Payments
- ELIQUIS (Drug) $918.26
- Corlanor (Drug) $738.08
- Repatha (Biological) $567.86
- ENTRESTO (Drug) $343.07
- Rhythmia Mapping System (Device) $282.21
- PRALUENT (Drug) $275.96
- PRADAXA (Drug) $275.40
- XARELTO (Drug) $242.23
- OPTIMIZER (Device) $208.25
- BRILINTA (Drug) $205.60
- PRALUENT ALIROCUMAB INJECTION (Biological) $176.90
- Optimizer (Device) $162.85
- INJECTAFER (Drug) $130.73
- MULTAQ (Drug) $112.14
- WATCHMAN (Device) $94.51
- NORTHERA (Drug) $90.83
- Veltassa (Drug) $84.83
- PRALUENT (Biological) $66.85
- LifeVest (Device) $52.04
- UTIBRON (Drug) $37.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.